filmov
tv
ESMO 2022 Duration of Androgen Deprivation Therapy with Post Operative
Показать описание
Juan Ignacio Caicedo
Educación Continuada “#FSFBedu”
Рекомендации по теме
0:10:59
ESMO 2022 Duration of Androgen Deprivation Therapy with Post Operative
0:02:21
#ESMO22 Highlights on ADT duration with post-operative radiotherapy in prostate cancer: RADICALS-HD
0:28:31
Prostate Cancer Highlights from ESMO 2022
0:00:52
Clinical trial updates in prostate cancer at ESMO 2022
0:01:19
Highlights in prostate cancer from ESMO
0:33:28
ESMO 2022: Highlights, commentary and analysis
0:06:41
ESMO Expert Report on combination therapy in advanced prostate cancer @ ASCO GU 2022
0:16:33
Genitourinary Cancer ESMO 2022 Highlights - OncBrothers (Rohit & Rahul Gosain) w/ Dr. Toni Choue...
0:04:47
ESMO: Critical Data on Apalitumide in Castrate Sensitive Prostate Cancer
0:26:35
ESMO 2021: Updates in hormone-sensitive prostate cancer
0:31:39
The evolving role of antibody-drug conjugates in the treatment of urothelial carcinoma
0:02:45
#ESMO21 Highlights on MFS analysis from comb. treatments in high-risk adv. prostate cancer: STAMPEDE
0:03:10
ESMO22 - first results of the RADICALS-HD trial (ISRCTN40814031)
0:04:56
Fred Saad, ESMO 2022: Phase III PROpel trial of abiraterone+olaparib in prostate cancer
0:04:36
Expert Report on latest data in the management of metastatic prostate cancer from ASCO 2022
0:05:27
PEACE-1: 8-month PSA determines outcomes in men with mCSPC
0:03:09
Prostate cancer updates at ESMO 2021: STAMPEDE and PEACE-1
0:01:37
ARCHES: OS in mHSPC who recieved prior ADT and reached low PSA further treated with enzalutamide
0:12:09
Prostate Cancer: Hormone Therapy Secrets Revealed! (all about Androgen Deprivation Therapy)
0:01:06
Highlights from ESMO TAT 2023 from Elena Garralda Cabanas
0:07:08
Expert video report on Prostate Cancer from 2021 Genitourinary Cancers Symposium
0:05:08
Androgen Deprivation Therapy and the Heart
0:10:38
Updates in Treatment Using ADT and Anti-Androgens
0:00:33
The rationale behind the ancillary study of the STAMPEDE AAP trial